Global Systemic Aspergillosis and Systemic Candidiasis Research Report 2024-2030 Featuring Sanofi, Cipla, Pfizer, GSK, Novartis, Bayer, Merck, F. Hoffmann-La Roche, Abbott, Gilead Sciences
May 24, 2024 06:32 ET
|
Research and Markets
Dublin, May 24, 2024 (GLOBE NEWSWIRE) -- The "Global Systemic Aspergillosis and Systemic Candidiasis Market (2024 Edition): Analysis By Type (Candidiasis, Aspergillosis), By Treatment Approach, By...
Global Tinea Pedis Treatment Market Projected to Reach USD 2.9 Billion by 2034, Fueled by Advancements in Treatment Options and Rising Prevalence
March 28, 2024 08:29 ET
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "Global Tinea Pedis Treatment Market" report has been added to ResearchAndMarkets.com's offering.The global tinea pedis treatment market size was...
Global Caspofungin Market Projected to Hit USD 590.5 Million by 2034, Asia Pacific Region to Witness Highest Growth Rate
January 31, 2024 08:19 ET
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Caspofungin Market" report has been added to ResearchAndMarkets.com's offering. New insights into the global caspofungin market have been...
Antifungals Global Market Report 2023: Major Players Include Pfizer, Novartis, Merck & Co and GlaxoSmithKline
April 04, 2023 06:59 ET
|
Research and Markets
Dublin, April 04, 2023 (GLOBE NEWSWIRE) -- The "Antifungals Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This report provides strategists, marketers and...
US Onychomycosis Market Size, Trends & Forecasts 2021-2025 Featuring Key Players - Bausch Health Companies, Pfizer, Novartis and Johnson & Johnson
May 31, 2021 08:23 ET
|
Research and Markets
Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "The US Onychomycosis Market: Size, Trends & Forecasts (2021-2025 Edition)" report has been added to ResearchAndMarkets.com's offering. This report...